Close Menu
    What's Hot

    Golden Visa Now in Reach: Settle in UAE for Just Rs.23 Lakh

    July 7, 2025

    Bank of Baroda Starts LBO Recruitment for 2500 Posts, Apply by July 24

    July 4, 2025

    Big Sell-Off by Promoters and Insiders Raises Investor Concerns

    July 4, 2025
    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram
    Invest PolicyInvest Policy
    Subscribe
    • Insurance
    • Investment
    • Tax
    • Stocks
    • MF
    • Money
    • Property
    • Schemes
    • More
      • Documents
      • Cards
      • Loan
      • Hindi
    Invest PolicyInvest Policy
    Home » Over 50 Medicines, Including Paracetamol and Telma, Fail Drug Quality Tests in India
    News

    Over 50 Medicines, Including Paracetamol and Telma, Fail Drug Quality Tests in India

    Shehnaz BeigBy Shehnaz BeigSeptember 26, 2024No Comments3 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email
    Over 50 Medicines, Including Paracetamol and Telma, Fail Drug Quality Tests in India
    Share
    Facebook Twitter LinkedIn Pinterest Email

    More than 50 popular medicines have failed the quality tests conducted by the Central Drugs Standard Control Organization (CDSCO), raising concerns about the safety of commonly used medications. The drugs that didn’t meet the standards include treatments for high blood pressure, diabetes, infections, and even everyday pain relievers like paracetamol. Some of these medications are manufactured by well-known pharmaceutical companies, sparking further alarm about counterfeit drugs in the market.

    Common Medications Fail Quality Standards

    According to CDSCO’s report for August, several top-selling medications, including paracetamol tablets, hypertension drug Telma H (Telmisartan 40 mg), and calcium supplements like Shelcal C and D3, have failed to meet quality standards. These medications are often used to treat common conditions like fever, high blood pressure, bacterial infections, and vitamin deficiencies.

    Some other drugs that failed the tests include:

    • Glimepiride (an anti-diabetic medicine)
    • Pan D (for acid reflux)
    • Metronidazole (an antibiotic)

    Several of these medicines are manufactured by reputable companies such as Alkem Laboratories, Hetero Drugs, and Hindustan Antibiotics Limited, among others.

    Counterfeit Concerns

    One of the most worrying aspects of the CDSCO report is the discovery of counterfeit medicines. Pharmaceutical companies like Sun Pharma and Glenmark have denied manufacturing the flagged batches of medicines, suggesting that these could be fake drugs sold under their brand names. Counterfeit drugs pose a serious risk to public health, as they may not only be ineffective but can also lead to dangerous side effects.

    A government laboratory in Kolkata found that drugs like Alkem Health Science’s Clavam 625 and Pan D, used for treating infections and acid reflux, did not meet quality standards. Hyderabad-based Hetero’s Cepodem XP 50 dry suspension, a medication for children with severe bacterial infections, was also flagged as substandard.

    See also  UP International Trade Show 2024: Everything You Need to Know, From Timings to Free Entry and Parking

    List of Affected Companies and Drugs

    Some of the companies whose drugs failed the quality tests include:

    • Alkem Laboratories (Clavam 625, Pan D)
    • Hetero Drugs (Cepodem XP 50)
    • Hindustan Antibiotics Limited (HAL) (Metronidazole)
    • Karnataka Antibiotics and Pharmaceuticals Limited (Paracetamol tablets)
    • Pure & Cure Healthcare (Shelcal D3)

    The findings indicate that these drugs do not conform to the set quality standards, which raises concerns about the safety and efficacy of the medications being sold in India.

    What the Companies Are Saying

    Many pharmaceutical companies have responded to the CDSCO’s findings by stating that they did not manufacture the drugs that failed the tests. For example, Sun Pharma, Glenmark, and Alkem Laboratories have all claimed that the flagged medicines were counterfeit versions being sold under their names.

    This has prompted further investigations to determine the origin of these fake drugs and ensure that only authentic medicines reach the market. The ongoing investigation aims to bring clarity on the issue and prevent the circulation of substandard or counterfeit drugs in the future.

    How to Protect Yourself from Counterfeit Drugs

    While buying medicines, you can take a few precautions to ensure that you are getting authentic, quality products:

    1. Purchase from licensed pharmacies and always ask for a bill.
    2. Check the packaging carefully. Low-quality printing or packaging could be a sign of counterfeit drugs.
    3. Verify the label for all the ingredients and compare them to what your doctor prescribed.
    4. Avoid buying medicines from unverified online sources without checking the legitimacy of the seller.

    By taking these steps, you can reduce the risk of purchasing counterfeit or substandard medicines.

    See also  Young Employee's Tragic Death Highlights Corporate Work Pressure: Mother Writes Emotional Letter to EY India Chairman
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email
    Previous ArticleLIC’s New Jeevan Shanti Plan: A Simple One-Time Investment for a Lifetime Pension of Rs. 1 Lakh!
    Next Article SIP vs RD: Understand the Differences to Make the Right Investment Choice
    Shehnaz Beig
    • LinkedIn

    Shehnaz Ali Siddiqui is a Corporate Communications Expert by profession and writer by Passion. She has experience of many years in the same. Her educational background in Mass communication has given her a broad base from which to approach many topics. She enjoys writing around Public relations, Corporate communications, travel, entrepreneurship, insurance, and finance among others.

    Related Posts

    Indian Techie Soham Parekh in Trouble for Handling 5 Jobs Together, Earns Over 2.5 Lakh a Day

    July 3, 2025

    Israel vs Iran: Why This Conflict Still Burns After Decades

    June 13, 2025

    Tension Rises: Is Israel Planning a Strike on Iran Before US-Iran Talks?

    June 12, 2025

    Rapido Enters Food Delivery: Can It Really Compete With Zomato & Swiggy?

    June 11, 2025

    Start Your Transport Business with Low Investment, Earn Monthly Income

    June 11, 2025

    Bharti Airtel: A Rising Star in Telecom, Favoured by Big Brokerages

    June 5, 2025
    Add A Comment

    Comments are closed.

    Top Posts

    Golden Visa Now in Reach: Settle in UAE for Just Rs.23 Lakh

    July 7, 2025

    Bank of Baroda Starts LBO Recruitment for 2500 Posts, Apply by July 24

    July 4, 2025

    Big Sell-Off by Promoters and Insiders Raises Investor Concerns

    July 4, 2025

    Subscribe to Updates

    Get the latest sports news from SportsSite about soccer, football and tennis.

    Advertisement

    Our main motto is to help our customers in making personal finance decisions easy and convenient as per their comfort. We are committed to provide accurate and unbiased information at your doorstep and keep it transparent among our customers.

    We're social. Connect with us:

    Facebook X (Twitter) Instagram Pinterest YouTube
    Top Insights

    Golden Visa Now in Reach: Settle in UAE for Just Rs.23 Lakh

    July 7, 2025

    Bank of Baroda Starts LBO Recruitment for 2500 Posts, Apply by July 24

    July 4, 2025

    Big Sell-Off by Promoters and Insiders Raises Investor Concerns

    July 4, 2025
    Get Informed

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    © 2025 Invest Policy. Designed by DigiSpiders.
    • Home
    • About Us
    • Contact Us
    • Privacy Policy
    • Terms and Conditions
    • Disclaimer

    Type above and press Enter to search. Press Esc to cancel.